Gayle M. Deflin's most recent trade in Amphastar Pharmaceuticals Inc was a trade of 11,402 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 11,402 | 11,402 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 5,122 | 10,914 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 6,864 | 6,864 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 3,076 | 5,792 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 7,016 | 7,016 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 2,716 | 6,879 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 18 May 2023 | 4,519 | 4,163 (0%) | 0% | 44.0 | 198,888 | Common Stock |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Sale of securities on an exchange or to another person at price $ 43.15 per share. | 15 May 2023 | 1,500 | 8,682 (0%) | 0% | 43.2 | 64,728 | Common Stock |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Amphastar Pharmaceuticals Inc | Gayle M. Deflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,163 | 10,182 (0%) | 0% | 0 | Common Stock |